Statins May Be Associated With Reduced Risk Of Cognitive Decline.

The Time (10/2, Park) “Healthland” blog reports that research published in Mayo Clinic Proceedings suggests that statins may be associated with a reduced risk of cognitive decline. Investigators analyzed data from “16 studies that involved people taking statin medications who were also tested on memory, attention and organizational skills,” and found “that longer term use of the drugs may prevent dementia.” Additionally, the researchers “found that use of statins for less than a year did not have any adverse effects on cognitive functions.” The article points out that last year, the FDA said that statins labels must carry warnings about an increased risk of memory problems.

Related Links:

— “Statin Drugs Linked to Lower Risk of Cognitive Decline, “Alice Park, Time, October 1, 2013.

Posted in In The News.